“A catastrophic moral failure”: COVID-19 and the political economy of access to medical technologies. Guest lecture for Harvard School of Public Health course "The Political Economy of Global Health." Boston, MA, 2021.
Fair or excessive? Estimating confidential pharmaceutical manufacturing costs and applications in law. Intellectual Property Law Discussion Group (IPDG). Oxford University, 2020.
Political Economy of Pharmaceutical Policy. Guest lecture for Harvard School of Public Health course "The Political Economy of Global Health." Boston, MA, 2019.
Agents of un-change: Implicating institutions and actors maintaining current health inequities. Decolonizing Global Health Conference. Boston, MA, 2019.
Countering information asymmetry in price negotiations: estimating the costs of production of medicines. Fifth Global Congress on Intellectual Property and the Public Interest. Washington DC, 2018.
Are prices of medicines influenced by production costs? Production costs for the medicines on the WHO Essential Medicines List [Keynote]. Pharmaceutical Pricing and Reimbursement Information (PPRI) Network Meeting. Stockholm, 2017.
How to calculate fair prices of antimicrobials - methodological and practical issues. European Congress of Clinical Microbiology and Infectious Diseases. Vienna, 2017.
Unexplained rises in UK cancer drug prices between 2011 and 2016. European Cancer Congress 2017, Amsterdam.
¿Cuál es el costo para producir un medicamento? Congreso internacional sobre acceso a medicamentos, tecnologías médicas y derechos humanos. Buenos Aires, 2016.
Declaration on patent protection: regulatory sovereignty under the TRIPS Agreement, The Max Planck Institute for Innovation and Competition and the University of South Africa College of Law. Pretoria, 2016